Format
Items per page
Sort by

Send to:

Choose Destination

Results: 6

Related Articles by Review for PubMed (Select 23632394)

1.

Sigma-1 receptor antagonism as opioid adjuvant strategy: enhancement of opioid antinociception without increasing adverse effects.

Vidal-Torres A, de la Puente B, Rocasalbas M, Touriño C, Bura SA, Fernández-Pastor B, Romero L, Codony X, Zamanillo D, Buschmann H, Merlos M, Baeyens JM, Maldonado R, Vela JM.

Eur J Pharmacol. 2013 Jul 5;711(1-3):63-72. doi: 10.1016/j.ejphar.2013.04.018. Epub 2013 Apr 28.

PMID:
23632394
3.

[Development of opioid tolerance -- molecular mechanisms and clinical consequences].

Freye E, Latasch L.

Anasthesiol Intensivmed Notfallmed Schmerzther. 2003 Jan;38(1):14-26. Review. German.

PMID:
12522725
4.

Sigma 1 receptor: a new therapeutic target for pain.

Zamanillo D, Romero L, Merlos M, Vela JM.

Eur J Pharmacol. 2013 Sep 15;716(1-3):78-93. doi: 10.1016/j.ejphar.2013.01.068. Epub 2013 Mar 13. Review.

PMID:
23500210
5.

Selective sigma-1 receptor antagonists for the treatment of pain.

Almansa C, Vela JM.

Future Med Chem. 2014 Jun;6(10):1179-99. doi: 10.4155/fmc.14.54. Review.

PMID:
25078137
6.

The pharmacology of sigma-1 receptors.

Maurice T, Su TP.

Pharmacol Ther. 2009 Nov;124(2):195-206. doi: 10.1016/j.pharmthera.2009.07.001. Epub 2009 Jul 18. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk